Restasis MultiDose

Allergan, Inc.🇺🇸 United States

FDA Page

Effective Date: Aug 21, 2025
Approval ID: 7224d810-bb96-4682-a942-3355e6e8061a
Products: 1 registered
Version: 9

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use RESTASIS MULTIDOSE safely and effectively. See full prescribing information for RESTASIS MULTIDOSE . RESTASIS MULTIDOSE ( cyclosporine ophthalmic emulsion ) 0.05% , f or topical ophthalmic use Initial U.S. Approval: 1983

Quick Stats

Total Products1

Labelers2

Label Sections30

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.